http://www.fda.gov/cvm/CVM_Updates/BSEUpdate043009.htm
CVM Update
<<Back
April 30, 2009
FDA Issues Final Guidance for Renderers on Substances Prohibited From Use in Animal Food or Feed
The Food and Drug Administration (FDA) today issued a final guidance document, “Small Entities Compliance Guide for Renderers – Substances Prohibited from use in Animal Food or Feed,” to provide guidance on the requirements of the final rule published in the Federal Register of April 25, 2008. This rule will further protect consumers against bovine spongiform encephalopathy (BSE), otherwise known as ‘mad cow disease.’
The purpose of the guidance document is to help rendering firms comply with the rule that became effective April 27, 2009. The guidance should also help slaughter facilities and farms supplying offal and dead livestock to the renderers understand their obligations under the rule. A copy of the final guidance can be found at http://www.fda.gov/cvm/Guidance/guide195.pdf.
The added measure of excluding high-risk materials from all animal feeds addresses risks associated with accidental feeding of such material to cattle, which could occur through cross-contamination of ruminant feed with non-ruminant feed or feed ingredients during manufacture and transport, or through misfeeding of non-ruminant feed to ruminants on the farm.
Comments on this guidance may be submitted any time to the Division of Dockets Management (HFA-305), Food and Drug Administration, 5630 Fishers Lane, Room 1061, Rockville, MD 20852. Comments may also be submitted electronically at http://www.regulations.gov. All written comments should be identified with Docket No. FDA-2008-D-0597.
For additional information on BSE and the final rule, please see: http://www.fda.gov/cvm/bsetoc.html.
For questions regarding this final document, please contact Shannon Jordre at FDA’s Center for Veterinary Medicine, 240-276-9229, shannon.jordre@fda.hhs.gov.
Issued by:
FDA, Center for Veterinary Medicine,
Communications Staff, HFV-12
7519 Standish Place, Rockville, MD 20855
Telephone: (240) 276-9300 FAX: (240) 276-9115
Internet Web Site: http://www.fda.gov/cvm
Web page updated by hd - April 30, 2009, 11:01 AM ET
Biden may have let the cat out of the bag !